EPHA2 and colorectal carcinoma: A study investigated the correlation between serum levels of EphA2 and VEGF-A and the pathogenesis of CRC, as well as the potential value of these molecules in the diagnosis of CRC, suggesting that the serum level of VEGF-A can be used as a potential serological marker for the diagnosis of CRC [31].